or Try an Advanced Search...

    Small Molecule Therapies Stocks List

    Symbol Grade Name % Change
    APTO F Aptose Biosciences, Inc. -11.72
    PRLD F Prelude Therapeutics Incorporated 0.86
    RAPT F RAPT Therapeutics, Inc. -1.87
    CTNM F Contineum Therapeutics, Inc. 4.69
    NRIX C Nurix Therapeutics, Inc. 0.72
    IVA C Inventiva S.A. -8.39
    EWTX C Edgewise Therapeutics, Inc. 0.85
    EXEL B Exelixis, Inc. 0.45
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Cancer Biotechnology Treatment Of Cancer Disease Life Sciences Lymphoma Phosphoinositide 3 Kinase Inhibitor Protein Kinase Inhibitor Solid Tumors Tyrosine Kinase Acute Myeloid Leukemia Alcohol Bacterial Infections Bemcentinib Biology Blastoma Bruton's Tyrosine Kinase Cancer Therapies Clinical Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Small Molecule Therapies stocks.

    Symbol Grade Name Weight
    IDNA D iShares Genomics Immunology and Healthcare ETF 8.13
    CNCR F Loncar Cancer Immunotherapy ETF 4.62
    FBT D First Trust Amex Biotech Index Fund 4.51
    CANC D Tema Oncology ETF 4.08
    PBE D PowerShares Dynamic Biotech & Genome 3.86
    View all Small Molecule Therapies ETFs...
    Compare ETFs
    Compare CANC to PBE Compare CNCR to CANC Compare IDNA to PBE

        Small Molecule Therapies Stocks Recent News

        Date Stock Title
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 20 IVA Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024
        Nov 20 IVA Combined General Meeting of December 11, 2024 - Availability of the preparatory documents
        Nov 20 APTO Aptose Initiates TUSCANY Phase 1/2 Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy
        Nov 20 EXEL Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
        Nov 18 IVA The first MASH drug could open the door for others — including GLP-1s
        Nov 17 NRIX Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
        Nov 15 IVA Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Cancer Biotechnology Treatment Of Cancer Disease Life Sciences Lymphoma Phosphoinositide 3 Kinase Inhibitor Protein Kinase Inhibitor Solid Tumors Tyrosine Kinase Acute Myeloid Leukemia Alcohol Bacterial Infections Bemcentinib Biology Blastoma Bruton's Tyrosine Kinase Cancer Therapies Clinical Medicine
        Small Molecule Therapies

        Small molecule therapies are drugs that are designed to target specific molecules in the body, such as proteins, enzymes, or receptors. These drugs are typically small molecules that can be easily absorbed and distributed throughout the body. They are used to treat a variety of diseases, including cancer, heart disease, and neurological disorders.

        Browse All Tags